SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-000758
Filing Date
2024-01-05
Accepted
2024-01-05 17:14:26
Documents
17
Period of Report
2023-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240104c_8k.htm   iXBRL 8-K 32892
2 EXHIBIT 10.1 ex_612467.htm EX-10.1 66974
3 EXHIBIT 10.2 ex_612468.htm EX-10.2 65409
4 EXHIBIT 10.3 ex_612469.htm EX-10.3 62929
9 mbrx20240104c_8kimg001.jpg GRAPHIC 4843
  Complete submission text file 0001437749-24-000758.txt   429017

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231229.xsd EX-101.SCH 3408
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231229_def.xml EX-101.DEF 11806
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231229_lab.xml EX-101.LAB 15857
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231229_pre.xml EX-101.PRE 12021
11 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240104c_8k_htm.xml XML 2647
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 24517489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)